5 Cheap Small-Cap Stocks to Buy Before the Next Breakout

Page 1 of 5

In this piece, we will take a look at five cheap small cap stocks to buy before the next breakout. If you want to take a deeper look at recent news about the small cap stocks then check out 11 Cheap Small-Cap Stocks to Buy Before the Next Breakout.

5. Inhibikase Therapeutics, Inc. (NASDAQ:IKT)

Number of Hedge Fund Investors In Q2 2023: 20

Latest Share Price: $1.97

Inhibikase Therapeutics, Inc. (NASDAQ:IKT) is a small biotechnology company developing treatments for Parkinson’s disease and other disorders. Its average share price target is $27, and the firm announced an improved version of its Parkinson’s treatment in August.

During Q2 2023, 20 out of the 910 hedge funds part of Insider Monkey’s database had invested in Inhibikase Therapeutics, Inc. (NASDAQ:IKT). Out of these, the firm’s largest shareholder is Steven Boyd’s Armistice Capital since it owns 496,547 shares that are worth $1.7 million.

Follow Inhibikase Therapeutics Inc.


Page 1 of 5